Travere Therapeutics Announces Planned Retirement of Chief Research Officer in 2027

Key Takeaway: Travere Therapeutics has announced the planned retirement of its Chief Research Officer in 2027. This decision marks a significant transition for the company as it prepares for future leadership changes. The announcement comes as part of the company's ongoing strategic planning efforts.